Items of Interest
Box 1: Director’s Program Development Funds(late 70’s - early 80’s). Fairly thorough
descriptions of (Senior Scientists’?) projects seeking funding. Alpen noteshis
recommendations to Dr. Shirley, Director of LBL at the time. Projects involved use of
human cells, lipoproteins, etc., animal studies, ultra-low dose diagnostic X-rays among
others.
In folder labeled: Director’s Program Development Funds(Director’s Funds) 1978
there is correspondenceoriginating from Dr. Durbin requesting fundsto publish
previously “unpublished Crocker Laboratory wartime research.” There is a list of 5
completely cited works which she wishesto include,all having to do with the Plutonium
Project. In a letter to Dr. Sessler she states: “In view of the important decisions that
must be made about nuclear power development and radioactive waste management,
and of the high degree of public criticism and questioning of radiation protection
standards, it seems wise to make the experimental methodology andthe original data
available for public scrutiny.” {Photocopied these documents.}
In folder labeled: “C” thereis a letter re: the sudden death of Dr. Joseph Garcia with the
recommendation that Gisela Clemonsbe his replacement, “as she is familiar with all
aspects of erythropoietin radioimmunoassay.” Attachedis a list of Outside
Collaboratorsof J.F. Garcia’s lab (with names, departments, addresses and phone
numbers.)
Box 2: In folder labeled June/July /August (1986) there is a note from Alpen to Henry
Stauffer, Chair, LBL Human Use Committeecriticizing the fact that Drs. Budinger and
Valk have been directly accessing Dr. Fabrikant’s AVM patients for NMR studies rather
than going through Dr. Fabrikant. Thereis a list of the Patient Numbersin question.
{Photocopied this document.}
In folder labeled Chron File 1983, in a letter dated October 27, 1983, Alpen expresses
concern about research on human subjects - “we have put severe constraints on the use